JDRF Blog

JDRF Blog

Information on research, events, activities, and news from the T1D community across Canada. 

Subscribe to the newsletter

First European clinical trial in human stem cell therapy for type 1 diabetes is underway

The development of encapsulation technologies to treat insulin-dependent diabetes has been at the forefront of type 1 diabetes (T1D) research in North...

Read More

7 Quick Tips for Drinking with Type 1 Diabetes

7 Quick Tips for Drinking with Type 1 Diabetes

We sat down with our JDRF Marketing & Communications summer student, Evelyn Riddell, who lives with type 1 diabetes (T1D) to get her quick tips on how to drink responsibly with T1D.


TEDDY study offers insights into causes of early T1D

TEDDY study offers insights into causes of early T1D

The Environmental Determinants of Diabetes in the Young (TEDDY) is following more than 7,000 at-risk children from infancy to 15 years of age to determine the causes of T1D.


Getting Real: My Experience Modelling with Type 1 Diabetes

Getting Real: My Experience Modelling with Type 1 Diabetes

Evelyn, our Marketing Communications Assistant for the summer, was featured in the latest bra campaign, and the T1D community is loving it!


Developing an insulin patch pump with open-protocol communication

Developing an insulin patch pump with open-protocol communication

Imagine an automated insulin delivery system that is able to connect with other devices seamlessly. A state-of-the-art, tubeless technology that provides continuous insulin therapy, operates on its own platform and publishes its own communication protocol.


New JDRF-funded study aims to prevent type 1 diabetes in infants

New JDRF-funded study aims to prevent type 1 diabetes in infants

Researchers at Oxford University (UK) are offering powdered insulin to babies at high risk of developing type 1 diabetes (T1D) with the hope of training their immune systems to tolerate the insulin they produce, thereby offering life-long protection against the disease.


JDRF and Gubra collaborate on the advancement of a new glucose-responsive insulin for diabetes

JDRF and Gubra collaborate on the advancement of a new glucose-responsive insulin for diabetes

JDRF has joined forces with Danish biotech company, Gubra, to develop a glucose-responsive insulin (GRI) as a treatment for people with insulin-dependent diabetes.


JDRF-funded research promoted at annual ADA conference

JDRF-funded research promoted at annual ADA conference

JDRF's leadership was highlighted at the American Diabetes Association's 78th Scientific Sessions. 


Our Guide to Navigating BBQ Season

Our Guide to Navigating BBQ Season

How to navigate BBQ season with type 1 diabetes. 


5 Ways Corporate Social Responsibility Can Engage Employees

5 Ways Corporate Social Responsibility Can Engage Employees

For Canadian business, philanthropic efforts are the best way to engage employees and induce positive culture. 


Our plan to fix the Disability Tax Credit is working: Here's why.

Our plan to fix the Disability Tax Credit is working: Here's why.

Why carbohydrate counting should be explicitly allowed for Disability Tax Credit eligibility.  A joint submission with Diabetes Canada.   


Lets turn type one into type none